ВОЗМОЖНОСТИ ПЕРСОНАЛИЗАЦИИ ФАРМАКОТЕРАПИИ ЯЗВЕННОЙ БОЛЕЗНИ В УСЛОВИЯХ ФУНКЦИОНИРОВАНИЯ СТАНДАРТОВ И ФОРМУЛЯРНОЙ СИСТЕМЫ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ

Helicobacter pylori (HP) eradication therapy is a compulsory component of the etiological treatment of HP-associated diseases, but modern standardized schemes of eradication therapy do not lead to complete destruction of HP. Determination of the phenotype of the oxidizing metabolism allows to personalize the dosage of the drugs in the treatment of the patients with peptic ulcer. This approach allows to reach maximum efficiency and eradicate HP, thus, making essential impact on the forecast of the disease and quality of life of the patients.